FDA approves first generic Advair Diskus  

出　　处：《Journal of Chinese Pharmaceutical Sciences》2019年第2期143-144,共2页中国药学（英文版）

摘　　要：The U.S.Food and Drug Administration today approved the first generic of Advair Diskus(fluticasone propionate and salmeterol inhalation powder)for the twice-daily treatment of asthma in patients aged four years and older and maintenance treatment of airflow obstruction and reducing exacerbations in patients with chronic obstructive pulmonary disease (COPD).

关 键 词：FDA Diskus EXACERBATIONS 

分 类 号：R95[医药卫生—药学]